MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 50 filers reported holding MEI PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $30,607 | -4.4% | 133,713 | +1073.0% | 0.00% | – |
Q2 2021 | $32,000 | -8.6% | 11,399 | +13.0% | 0.00% | – |
Q1 2021 | $35,000 | -27.1% | 10,089 | -13.5% | 0.00% | – |
Q2 2020 | $48,000 | +26.3% | 11,667 | -50.9% | 0.00% | – |
Q1 2020 | $38,000 | -7.3% | 23,741 | -2.6% | 0.00% | – |
Q3 2019 | $41,000 | -88.6% | 24,384 | -83.1% | 0.00% | -100.0% |
Q2 2019 | $361,000 | – | 144,570 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
Artal Group S.A. | 1,000,000 | $244 | 0.01% |
Annandale Capital, LLC | 100,000 | $24 | 0.01% |
ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |